Fused ring heterocycle kinase modulators

A compound having formula II:

• or an enantiomer, diastereomer, racemate or pharmaceutically acceptable salt thereof, wherein:
• L1 and L2 are each independently a bond, —S(O)n—, —O—, —NH—, unsubstituted C1-C5 alkylene, or unsubstituted 2 to 5 membered heteroalkylene, wherein n is an integer from 0 to 2;
• and
• R1 and R2 are each independently substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted aryl.